SMTL ID : 4acd.1

GSK3b in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-dimer

Ligands

2 x GR9: 3-AMINO-6-{4-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE(Non-covalent)

GR9.1: 17 residues within 4Å: Chain A: K.105, F.112, V.115, A.128, K.130, V.155, L.177, D.178, Y.179, V.180, P.181, E.182, T.183, R.186, L.233, C.244, D.245 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.112, A:V.115, A:T.183, A:L.233, A:D.245 Hydrogen bonds: A:D.178, A:V.180, A:R.186 Water bridges: A:D.245 GR9.2: 17 residues within 4Å: Chain B: I.107, F.112, V.115, A.128, K.130, V.155, L.177, D.178, Y.179, V.180, P.181, E.182, T.183, R.186, L.233, C.244, D.245 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:F.112, B:V.115, B:T.183, B:L.233, B:D.245 Hydrogen bonds: B:D.178, B:V.180 Water bridges: B:D.245 Salt bridges: B:E.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Berg, S. et al., Discovery of novel potent and highly selective glycogen synthase kinase-3 beta (GSK3 beta ) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines. J. Med. Chem. (2012)

Release Date

2012-05-16

Peptides

GLYCOGEN SYNTHASE KINASE-3 BETA: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

GLYCOGEN SYNTHASE KINASE-3 BETA

Related Entries With Identical Sequence